Business Description
NetraMark Holdings Inc. is a Toronto-based company founded in 2016 that helps drug developers and research organizations get more out of their clinical trial data. Its core product is an AI platform designed to find meaningful patterns within complex patient data, helping clients better understand which groups of people respond to treatments. The company was previously called Nurosene Health Inc. before rebranding in February 2023.
